NeuroSigma, Inc. — Form D/A
NeuroSigma, Inc. of LOS ANGELES, CA, a company, filed a Form D amendment with the SEC on 2011-03-10. The offering totals $5.0M, of which $1.2M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2011-03-10
- Form: D/A
- Accession: 0001181431-11-016984
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $5.0M
- Amount sold: $1.2M
- Remaining: $3.8M
- Minimum investment: $50K
- Investors: 11
- Date of first sale: 2010-06-08
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-143915
Issuer
- Name: NeuroSigma, Inc.
- CIK: 0001494756
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2008
- Address: 10960 WILSHIRE BLVD., LOS ANGELES, CA, 90024
- Phone: (310) 479-3100
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Leon Ekchian | Director | Los Angeles, CA |
| Leon Ekchian | Executive Officer | Los Angeles, CA |
| Kirk M Calhoun | Director | Los Angeles, CA |
| Lodwrick M Cook | Director | Los Angeles, CA |
| James M Hindman | Director | Los Angeles, CA |
Other filings by this issuer (3)
More